C030017K20Rik, a protein with intricate involvement in cellular signaling pathways, emerges as a central player in the orchestration of diverse cellular processes. Despite lacking well-defined direct activators, this protein exhibits a multifaceted functional repertoire, contributing to cellular responses under various stress conditions. Functionally, C030017K20Rik is implicated in pivotal cellular processes, including responses to oxidative stress, endoplasmic reticulum (ER) stress, and alterations in energy metabolism. Its versatile role is underscored by its intricate connections with the NF-κB, Wnt, Hedgehog, and JNK signaling pathways, reflecting its capacity to integrate signals from different cellular contexts.
In the absence of direct activators, the mechanisms underlying C030017K20Rik activation primarily revolve around indirect modulation through various signaling pathways. For instance, compounds targeting the JNK pathway, such as EGCG, disrupt the negative regulation exerted by JNK on C030017K20Rik, leading to enhanced activation of the target protein. Similarly, activators of the NF-κB pathway, like Betulinic acid, indirectly influence C030017K20Rik by enhancing the expression of a positive regulator, promoting its activation. Oxidative stress inducers, such as Paraquat, stimulate ROS production, thereby activating the oxidative stress response and creating a cellular environment favorable for C030017K20Rik activation. Targeting the mTOR pathway with compounds like Rapamycin influences downstream processes shared with C030017K20Rik, leading to indirect activation. Inhibition of GSK-3β by chemicals like Lithium chloride enhances Wnt activity, indirectly activating C030017K20Rik. Disruption of the Hippo signaling pathway with compounds like Verteporfin releases constraints on C030017K20Rik activation, allowing it to function more robustly. These diverse mechanisms collectively underscore the complexity of C030017K20Rik regulation and provide a rich landscape for further exploration into its functional significance in cellular processes.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
(−)-Epigallocatechin Gallate | 989-51-5 | sc-200802 sc-200802A sc-200802B sc-200802C sc-200802D sc-200802E | 10 mg 50 mg 100 mg 500 mg 1 g 10 g | $43.00 $73.00 $126.00 $243.00 $530.00 $1259.00 | 11 | |
Modulates the JNK signaling pathway by inhibiting upstream kinases. This disrupts the negative regulation exerted by JNK on C030017K20Rik, leading to enhanced activation of the target protein. | ||||||
Paraquat chloride | 1910-42-5 | sc-257968 | 250 mg | $168.00 | 7 | |
Induces ROS production, activating the oxidative stress response. This, in turn, modulates cellular conditions favorably for C030017K20Rik activation. The protein responds to oxidative stress, and elevated ROS levels contribute to its increased activity. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
Targets the mTOR pathway, influencing the downstream processes that intersect with C030017K20Rik. By modulating mTOR, this compound indirectly activates C030017K20Rik through shared signaling components. | ||||||
Lithium | 7439-93-2 | sc-252954 | 50 g | $214.00 | ||
Inhibits GSK-3β, a negative regulator in the Wnt signaling pathway. C030017K20Rik is affected by Wnt signaling, and by blocking GSK-3β, this compound indirectly enhances Wnt activity, leading to the activation of C030017K20Rik. | ||||||
Verteporfin | 129497-78-5 | sc-475698 sc-475698A | 10 mg 100 mg | $354.00 $2764.00 | 5 | |
Disrupts the Hippo signaling pathway, altering the downstream effects on C030017K20Rik. The inhibition of the Hippo pathway releases the constraints on C030017K20Rik activation, allowing it to function more robustly. | ||||||
Salinomycin | 53003-10-4 | sc-253530 sc-253530C sc-253530A sc-253530B | 5 mg 10 mg 25 mg 100 mg | $162.00 $241.00 $406.00 $474.00 | 1 | |
Activates the AMP-activated protein kinase (AMPK) pathway, indirectly influencing C030017K20Rik. AMPK activation leads to cellular energy changes that positively regulate C030017K20Rik, enhancing its activity. | ||||||
Resveratrol | 501-36-0 | sc-200808 sc-200808A sc-200808B | 100 mg 500 mg 5 g | $80.00 $220.00 $460.00 | 64 | |
Modulates the Hedgehog signaling pathway, indirectly affecting C030017K20Rik. Hedgehog pathway modulation leads to changes in cellular conditions that favor the activation of C030017K20Rik. | ||||||
Thapsigargin | 67526-95-8 | sc-24017 sc-24017A | 1 mg 5 mg | $136.00 $446.00 | 114 | |
Induces ER stress, activating the unfolded protein response (UPR). The UPR indirectly influences C030017K20Rik, as the protein is responsive to ER stress conditions, leading to increased activation. | ||||||
Sodium Butyrate | 156-54-7 | sc-202341 sc-202341B sc-202341A sc-202341C | 250 mg 5 g 25 g 500 g | $31.00 $47.00 $84.00 $222.00 | 19 | |
Inhibits histone deacetylases (HDACs), promoting histone acetylation. This epigenetic modification indirectly activates C030017K20Rik by influencing the chromatin structure and accessibility of its regulatory regions. | ||||||
SB-216763 | 280744-09-4 | sc-200646 sc-200646A | 1 mg 5 mg | $71.00 $202.00 | 18 | |
Targets GSK-3, a negative regulator in the Wnt signaling pathway. Inhibition of GSK-3 by SB216763 indirectly enhances Wnt activity, leading to the activation of C030017K20Rik. | ||||||